Gainers

• Immutep (NASDAQ:IMMP) shares rose 135.4% to $0.74 during Wednesday's pre-market session. The market value of their outstanding shares is at $46.3 million.
• ENDRA Life Sciences (NASDAQ:NDRA) stock moved upwards by 13.1% to $5.61. The market value of their outstanding shares is at $6.1 million.
• Medicus Pharma (NASDAQ:MDCX) stock moved upwards by 12.15% to $0.45. The company's market cap stands at $11.9 million.
• Liminatus Pharma (NASDAQ:LIMN) stock rose 9.53% to $0.2. The market value of their outstanding shares is at $7.0 million.
• BrainsWay (NASDAQ:BWAY) stock moved upwards by 8.41% to $16.23. The company's market cap stands at $599.2 million.
• Acurx Pharmaceuticals (NASDAQ:ACXP) stock increased by 7.55% to $2.99. The market value of their outstanding shares is at $7.9 million.

Losers

• Aspire Biopharma Holdings (NASDAQ:ASBP) stock fell 28.2% to $0.85 during Wednesday's pre-market session. The company's market cap stands at $5.9 million.
• HeartBeam (NASDAQ:BEAT) stock fell 25.36% to $0.9. The company's market cap stands at $49.3 million.
• Curanex Pharmaceuticals (NASDAQ:CURX) stock fell 24.99% to $0.35. The company's market cap stands at $13.1 million.
• Wellgistics Health (NASDAQ:WGRX) shares fell 20.2% to $0.12. The company's market cap stands at $18.3 million.
• Clearmind Medicine (NASDAQ:CMND) shares declined by 16.58% to $0.76. The market value of their outstanding shares is at $2.1 million.
• Aligos Therapeutics (NASDAQ:ALGS) stock fell 14.88% to $7.44. The company's market cap stands at $54.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.